DermaScan
PrivateLast Round
Seed
Feb 2, 2026
Total Funding Raised
$2.96M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DermaScan is a healthcare company that operates expert centers for skin cancer screening, combining clinical examinations, total body mapping, and technological innovations to provide early detection.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Fashion & Beauty, Biotechnology, Medical Devices, Compliance
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermaScan Comparables
Compare DermaScan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zurko Research | 88% | |
| Atlantia Clinical Trials | 77% | |
| Eurofins Scientific SE | 72% |
DermaScan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 2, 2026 |
Key People
Founding team and executive leadership
DermaScan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kima Ventures | Seed |
| Hexa | Seed |
| Techmind | Seed |
| Ring Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased from 0 to 4, representing 27% of headcount.
- Apr 25, 2026
Grew 36% QoQ, from 11 to 15 employees.
DermaScan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access